These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19747314)

  • 1. Unusual location of purpura fulminans associated with acquired protein C deficiency and administration of propylthiouracil.
    Akman A; Dicle O; Ciftcioglu MA; Alpsoy E
    Clin Exp Dermatol; 2009 Oct; 34(7):e463-4. PubMed ID: 19747314
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichenoid drug eruption of nails induced by propylthiouracil.
    Saito M; Nakamura K; Kaneko F
    J Dermatol; 2007 Oct; 34(10):696-8. PubMed ID: 17908140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy.
    Sheen YS; Chu CY; Yu HS
    Arch Dermatol; 2006 Jul; 142(7):879-80. PubMed ID: 16847204
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein C (PROC) gene mutations in two Indian families with purpura fulminans.
    Pai N; Shetty S; Ghosh K
    Ann Hematol; 2010 Aug; 89(8):835-6. PubMed ID: 20077116
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal purpura fulminans due to protein C deficiency.
    Sharma S; Anbazhagan J; Plakkal N
    Arch Dis Child Fetal Neonatal Ed; 2015 Sep; 100(5):F453. PubMed ID: 25783192
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe purpura fulminans due to coexistence of homozygous protein C deficiency and homozygous methylenetetrahydrofolate reductase mutation.
    Demirel N; Bas AY; Okumus N; Zenciroglu A; Yarali N
    Pediatr Hematol Oncol; 2009 Nov; 26(8):597-600. PubMed ID: 19954370
    [No Abstract]   [Full Text] [Related]  

  • 7. Propylthiouracil-induced cutaneous vasculitis.
    Yarman S; Sandalci O; Tanakol R; Azizlerli H; Oguz H; Alagöl F
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):282-6. PubMed ID: 9247841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Purpura lesions and alveolar infiltrates: propylthiouracil-induced vasculitis].
    Sanz Marcos N; Felipe Villalobos A; Antón López J; Ros Viladoms J; Rodríguez Hierro F
    An Pediatr (Barc); 2009 Mar; 70(3):315-7. PubMed ID: 19409257
    [No Abstract]   [Full Text] [Related]  

  • 9. Purpura fulminans from acquired protein C deficiency in the era of COVID-19: a case report.
    Rostami S; Martinez SL; Kawaji Q; Lagziel T; Hultman CS; Caffrey J
    Int J Dermatol; 2023 Jun; 62(6):835-836. PubMed ID: 37159515
    [No Abstract]   [Full Text] [Related]  

  • 10. Purpura fulminans in congenital protein C deficiency successfully treated with fresh frozen plasma and thrombomodulin.
    Hayami T; Yamaguchi A; Kato T; Tanaka T; Nishizawa Y; Yanagi T; Taga T; Matsumoto S; Uchiumi T; Fujimoto N
    J Dermatol; 2018 Jun; 45(6):e165-e166. PubMed ID: 29265490
    [No Abstract]   [Full Text] [Related]  

  • 11. Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease.
    Ligier S; Pham CD; Watters AK; Kassis J; Fortin PR
    Scand J Rheumatol; 2002; 31(6):371-3. PubMed ID: 12492254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal purpura fulminans without sepsis due to a severe congenital protein C deficiency].
    Hmami F; Cherrabi H; Oulmaati A; Bouabdallah Y; Bouharrou A
    Arch Pediatr; 2015 Oct; 22(10):1027-31. PubMed ID: 26228809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purpura fulminans: recognition, diagnosis and management.
    Chalmers E; Cooper P; Forman K; Grimley C; Khair K; Minford A; Morgan M; Mumford AD
    Arch Dis Child; 2011 Nov; 96(11):1066-71. PubMed ID: 21233082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-associated purpura fulminans and multiple deep vein thromboses: a case report.
    Dogan M; Acikgoz M; Bora A; Başaranoğlu M; Oner AF
    J Nippon Med Sch; 2009 Jun; 76(3):165-8. PubMed ID: 19602824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in protein C gene (PROC) causing severe phenotype in neonatal period.
    Unal S; Gumruk F; Yigit S; Tuncer M; Tavil B; Cil O; Takci S; Urata M; Hotta T; Kang D; Cetin M
    Pediatr Blood Cancer; 2014 Apr; 61(4):763-4. PubMed ID: 24115609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal purpura fulminans due to homozygous protein C deficiency.
    Ezer U; Misirlioglu ED; Colba V; Ogoz E; Kurt C
    Pediatr Hematol Oncol; 2001; 18(7):453-8. PubMed ID: 11594708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent vasculopathic skin lesions associated with homozygous protein C deficiency.
    Agras PI; Ozdemir H; Baskin E; Ozbek N
    Pediatr Dermatol; 2007; 24(1):57-60. PubMed ID: 17300652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel management of post varicella purpura fulminans owing to severe acquired protein S deficiency.
    Thomson JJ; Retter A; Hunt BJ
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):598-600. PubMed ID: 20625278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thionamide-induced vasculitis: a case of alveolar haemorrhage secondary to propylthiouracil.
    El-Fakih R; Chehab BM; Shaver T
    J Intern Med; 2008 Dec; 264(6):610-2. PubMed ID: 18624905
    [No Abstract]   [Full Text] [Related]  

  • 20. Fulminant hepatic failure associated with propylthiouracil: a case report with treatment emphasis on the use of plasmapheresis.
    Aydemir S; Ustundag Y; Bayraktaroglu T; Tekin IO; Peksoy I; Unal AU
    J Clin Apher; 2005 Dec; 20(4):235-8. PubMed ID: 16206173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.